Impact of Mobile Text Messaging on Follow Up Rates After Discharge From the Pediatric Emergency Department
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03674879|
Recruitment Status : Withdrawn (PI left facility)
First Posted : September 18, 2018
Last Update Posted : September 18, 2018
|Condition or disease||Intervention/treatment||Phase|
|Duty to Recontact||Other: Text Message||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||0 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Impact of Mobile Text Messaging on Follow Up Rates After Discharge From the Pediatric Emergency Department|
|Study Start Date :||September 2016|
|Estimated Primary Completion Date :||August 2017|
|Estimated Study Completion Date :||December 2017|
No Intervention: Phone Call
Follow up contact is attempted via phone call.
Experimental: Text Message
Follow up contact is attempted via text message.
Other: Text Message
Patient contact attempted with text message.
- Number of phone call or text message attempts to successful contact with study participant [ Time Frame: Within 2 weeks. ]A study practitioner will make one attempt per business day to contact the patient or caregiver to provide test results and arrange follow-up care; the method will be determined by the study arm to which the participant is assigned. Participants in the standard practice control arm will receive a telephone call. If a call is not answered, a voice message will be left instructing the patient/parent to call the Pediatric Follow-Up Office. Participants in the intervention arm will receive a text message using the same script. A successful contact will be recorded when a practitioner speaks directly to the patient or parent/guardian via phone.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03674879
|Principal Investigator:||Czer Anthoney E Lim, MD||Jacobi Medical Center/Albert Einstein College of Medicine|